Rare diseases
Investigational molecules
Locations
Back to Bulgaria437 clinical trials in Plovdiv, Bulgaria across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis
BulgariaStudy on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials
BulgariaStudy on Lumateperone for Patients with Major Depressive Disorder Not Responding to Antidepressants
BulgariaStudy on the Long-Term Safety of Finerenone with ACE Inhibitors or ARBs for Children and Young Adults with Chronic Kidney Disease and Proteinuria
BulgariaStudy Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera
BulgariaContinued Access Study for Patients with Severe Hemophilia A Using Efanesoctocog Alfa
BulgariaStudy on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis
BulgariaStudy on Lisaftoclax and Acalabrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
BulgariaLong-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis
BulgariaStudy of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels
BulgariaStudy on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors
BulgariaStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Ongoing research focuses on influenza virus prevention and hepatitis delta infection treatment. Clinical trials are evaluating new vaccine formulations and therapeutic approaches for viral infections.
Studies include testing of adjuvanted vaccines and novel antiviral medications for chronic conditions.
Research initiatives targeting hypertriglyceridemia and heart failure prevention. Studies are exploring innovative treatments for metabolic conditions and cardiovascular risk reduction.
Trials evaluate new compounds for managing metabolic disorders and preventing cardiovascular events.
Comprehensive studies on psoriatic arthritis, Sjögren's disease, and systemic sclerosis. Research focuses on innovative biological therapies and treatment approaches.
Clinical trials are investigating novel therapeutic agents for managing chronic autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
